Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)

This study has been completed.

Sponsor:

Information provided by:

Wellstat Therapeutics

ClinicalTrials.gov Identifier:

NCT00110851

First received: May 13, 2005

Last updated: August 21, 2007

Last verified: August 2007

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	August 2007
Estimated Primary Completion Date:	No date given